US Compounding Enrofloxacin+Ketoconazole+Triamcinolone
Recall announced July 1, 2020 by US Compounding Inc, posted by the U.S. Food and Drug Administration (FDA). Reason: CGMP deviations. The agency has closed this recall.
- Where sold
- AR, CO, OK, PA
- Last updated
- November 19, 2026
Products included
- Enrofloxacin+Ketoconazole+Triamcinolone, 0.5%/1%/0.1%, Otic in Pluronic in 30 mL syringes NDC 22200960806 (Lot: 06262020@2 BUD: 09/24/2020)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
